ப்ரொஃப் பால் மோர்கன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ரொஃப் பால் மோர்கன். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ரொஃப் பால் மோர்கன் Today - Breaking & Trending Today

What does the first Alzheimer's drug to be approved in 20 years mean for those who have been diagnosed?

Aduhelm slows the disease s progress, but there are questions over its efficacy - and its $50,000 price tag ....

City Of , United Kingdom , United States , Paul Matthews , Rob Howard , Paul Morgan , Ivan Koychev , Liz Coulthard , University College London , University Of Oxford Department Psychiatry , Drug Administration , Imperial College London , Alzheimer Association , European Medicines Agency , University Of Bristol , American Geriatrics Society , Imperial College , Prof Paul Morgan , United Kingdom Dementia Research Institute , Prof Morgan , University College , Prof Rob Howard , Massachusetts Based Biogen , Brain Sciences , Prof Paul Matthews , Prof Matthews ,

What does the first Alzheimer's drug to be approved in 20 mean for sufferers?

Aduhelm slows the disease s progress, but there are questions over its efficacy - and its $50,000 price tag ....

City Of , United Kingdom , United States , Paul Matthews , Rob Howard , Paul Morgan , Ivan Koychev , Liz Coulthard , University College London , University Of Oxford Department Psychiatry , Drug Agency , Imperial College London , Alzheimer Association , European Medicines Agency , University Of Bristol , American Geriatrics Society , Imperial College , Prof Paul Morgan , United Kingdom Dementia Research Institute , Prof Morgan , University College , Prof Rob Howard , Massachusetts Based Biogen , Brain Sciences , Prof Paul Matthews , Prof Matthews ,

Why has Germany advised against Oxford/AstraZeneca jab for over-65s?

Last modified on Thu 28 Jan 2021 18.58 EST
German authorities have advised that the Oxford/AstraZeneca jab should not be given to those aged 65 or above. We take a look at why, and what experts make of it.
Why has Germany advised the Oxford/AstraZeneca jab should only be used in adults under 65?
The issue boils down to a lack of data on efficacy of the vaccine in this age group. The standing committee on vaccination of the Robert Koch Institute, Germany’s disease control agency, said: “There is insufficient data to judge how effective the vaccination is above 65 years.”
Writing in their Lancet study released last year, researchers said there were not enough Covid cases among older adults at the time to explore just how well the vaccine protected them against the disease. ....

United Kingdom , City Of , Astrazeneca Oxford , Simon Clarke , Paul Morgan , Oxford Astrazeneca , Stephen Evans , Randy Pollard , Danny Altmann , London School Of Hygiene Tropical Medicine , University Of Oxford , Cardiff University , Regulatory Agency , University Of Reading , Imperial College London , European Medicines Agency , Robert Koch Institute , Prof Paul Morgan , Prof Stephen Evans , London School , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , சிமோன் கிளார்க் , பால் மோர்கன் , ஸ்டீபன் எவன்ஸ் , ஆண்டி பொழிலர்ட் ,